4.6 Article

Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

A roadmap to increase diversity in genomic studies

Segun Fatumo et al.

Summary: This article describes the factors contributing to the imbalance in representation of different populations in genetic and genomic studies, and proposes a roadmap to enhance inclusion and ensure equal health benefits of genomics advances. The authors emphasize the importance of global efforts to ensure that everyone can benefit from genomic medicine.

NATURE MEDICINE (2022)

Article Cell Biology

The biobank of barretos cancer hospital: 14 years of experience in cancer research

Ana Caroline Neuber et al.

Summary: Despite advancements in cancer research, cancer remains a leading cause of death globally, with Brazil expecting a rise in cancer cases. The Barretos Cancer Hospital's biobank (BB-BCH) has been crucial in processing biological materials for research and supporting translational oncology studies in Brazil by ensuring high-quality standards and a diverse sample collection.

CELL AND TISSUE BANKING (2022)

Review Multidisciplinary Sciences

Early detection of cancer

David Crosby et al.

Summary: Early detection of cancer is crucial for improving survival rates, but unfortunately, a significant number of cases are diagnosed at an advanced stage. Overcoming various challenges is essential to achieve early detection for all cancers, including understanding high-risk individuals, elucidating the biology and trajectory of precancer and early cancer, and developing sensitive and specific detection technologies.

SCIENCE (2022)

Article Oncology

The Performance of Colorectal Cancer Screening in Brazil: The First Two Years of the Implementation Program in Barretos Cancer Hospital

Denise Peixoto Guimaraes et al.

Summary: The study presented the quality/performance measures of BCH's FIT-based organized colorectal cancer screening program in the first 2 years and its impact on colorectal cancer disease stage. The program achieved desirable quality metrics and resulted in screening-detected cancers being at earlier stages compared to clinically diagnosed cases.

CANCER PREVENTION RESEARCH (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Multidisciplinary Sciences

Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer

Zhi Yao Ma et al.

Summary: SEPT9 ddPCR showed good performance in CRC detection, and the rapid decline of methylated SEPT9 abundance 3 months after surgery may be helpful for monitoring treatment response.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex

Mercedes Vanaclocha-Espi et al.

Summary: The study on fecal immunological tests indicates that selecting optimal cut-off values for different age and sex groups can improve colorectal cancer screening sensitivity, reduce the need for further testing after negative results, but also lead to an increase in false positive diagnoses.

PLOS ONE (2021)

Article Gastroenterology & Hepatology

Methylation profile of colon cancer genes in colorectal precursor lesions and tumor tissue: perspectives for screening

Thais Sobanski et al.

Summary: Epigenetic alterations of SEPT9, ALX4, NDRG4, and BMP3 genes are common in colorectal cancer and precursor lesions, with significantly higher methylation frequencies in tumors compared to normal colon tissues. These genes show potential as informative biomarkers for early detection and screening of CRC in the Brazilian population.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Oncology

Colorectal cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Gastroenterology & Hepatology

Epigenetics of colorectal cancer: biomarker and therapeutic potential

Gerhard Jung et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Non-Invasive Colorectal Cancer Screening: An Overview

Melanie Tepus et al.

GASTROINTESTINAL TUMORS (2020)

Article Multidisciplinary Sciences

Hypermethylated DNA, a circulating biomarker for colorectal cancer detection

Simon Ladefoged Rasmussen et al.

PLOS ONE (2017)

Article Gastroenterology & Hepatology

Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening

Cristina Alvarez-Urturi et al.

DIGESTIVE AND LIVER DISEASE (2016)

Article Gastroenterology & Hepatology

Colorectal cancer screening: a global overview of existing programmes

Eline H. Schreuders et al.

Article Medicine, General & Internal

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

Thomas F. Imperiale et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Gastroenterology & Hepatology

Serrated pathway in colorectal carcinogenesis

Leticia Yamane et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

The Stool DNA Test Is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia

David A. Ahlquist et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Medicine, General & Internal

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

Jorja D. Warren et al.

BMC MEDICINE (2011)

Review Oncology

Epigenetics in cancer

Shikhar Sharma et al.

CARCINOGENESIS (2010)

Article Medical Laboratory Technology

Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer

Theo deVos et al.

CLINICAL CHEMISTRY (2009)

Article Medical Laboratory Technology

DNA methylation biomarkers for blood-based colorectal cancer screening

Catherine Lofton-Day et al.

CLINICAL CHEMISTRY (2008)

Article Oncology

Free circulating DNA as possible tumour marker in colorectal cancer

L. Boni et al.

SURGICAL ONCOLOGY-OXFORD (2007)

Review Genetics & Heredity

The fundamental role of epigenetic events in cancer

PA Jones et al.

NATURE REVIEWS GENETICS (2002)